BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 131 filers reported holding BIOSCRIP INC in Q4 2013. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | 0.0% | 1,100 | +120.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 500 | +66.7% | 0.00% | – |
| Q1 2018 | $1,000 | -66.7% | 300 | -89.8% | 0.00% | – |
| Q4 2016 | $3,000 | -66.7% | 2,936 | -41.5% | 0.00% | – |
| Q4 2015 | $9,000 | -87.8% | 5,021 | -87.3% | 0.00% | -100.0% |
| Q3 2015 | $74,000 | -86.9% | 39,531 | -74.6% | 0.00% | -87.5% |
| Q2 2015 | $565,000 | +1612.1% | 155,767 | +1971.9% | 0.01% | +700.0% |
| Q1 2015 | $33,000 | +43.5% | 7,518 | +124.8% | 0.00% | – |
| Q3 2014 | $23,000 | -77.5% | 3,344 | -72.6% | 0.00% | -100.0% |
| Q2 2014 | $102,000 | -66.9% | 12,199 | -72.3% | 0.00% | -60.0% |
| Q1 2014 | $308,000 | +25.2% | 44,101 | +32.7% | 0.01% | +25.0% |
| Q4 2013 | $246,000 | +6.5% | 33,244 | +26.3% | 0.00% | 0.0% |
| Q3 2013 | $231,000 | – | 26,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coliseum Capital Management, LLC | 5,622,410 | $5,847,000 | 2.64% |
| NORTH TIDE CAPITAL, LLC | 8,500,000 | $8,840,000 | 1.51% |
| WYNNEFIELD CAPITAL INC | 3,700,000 | $3,848,000 | 1.39% |
| Alta Fundamental Advisers LLC | 2,330,774 | $2,424,000 | 1.20% |
| ARDSLEY ADVISORY PARTNERS LP | 6,350,000 | $6,604,000 | 1.09% |
| Camber Capital Management LP | 10,180,000 | $10,587,000 | 0.55% |
| PERKINS CAPITAL MANAGEMENT INC | 298,000 | $310,000 | 0.34% |
| Hawk Ridge Capital Management | 340,429 | $354,000 | 0.18% |
| Eidelman Virant Capital | 220,000 | $228,000 | 0.13% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 227,280 | $236,000 | 0.11% |